Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.85 +0.13 (+1.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Total Debt (2021 - 2026)

Updated

Aspire Biopharma Holdings' Total Debt was $499,214 in Q1 2026, down 88.6% from $4.39 million a year earlier and down 79.1% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Total Debt (2021 - 2026) Analysis & Trends

At the end of FY2025, Total Debt at Aspire Biopharma Holdings came in at $2.39 million, down 84.6% from FY2024.

  • Total Debt shows a four-year compound annual growth rate of 77.8% (FY2021 to FY2025).
  • In earlier years, Total Debt was $15.53 million in FY2024, $373,020 in FY2023 and $238,596 in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Total Debt since Q1 2024.
  • Compared with a year earlier, Total Debt was higher in two of the last four quarters, with an average decline of 42.2%.
  • Per Business Quant data, ASBP's Total Debt in the three quarters before Q1 2026 was $2.39 million (Q4 2025), $5.63 million (Q3 2025) and $4.95 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 499,214.00
Dec 31, 2025 5.18 Mn
Sep 30, 2025 7.13 Mn
Jun 30, 2025 7.47 Mn
Mar 31, 2025 6.76 Mn
Dec 31, 2024 15.99 Mn
Sep 30, 2024 5.40 Mn
Jun 30, 2024 5.36 Mn
Mar 31, 2024 217,232.00
Dec 31, 2023 373,020.00
Dec 31, 2021 238,596.00
API Access

Aspire Biopharma Holdings, Inc. Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ASBP&period=max&api_key=YOUR_API_KEY